These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29177488)

  • 1. A REVIEW OF ANALYTICAL MODELS OF STRAY RADIATION EXPOSURES FROM PHOTON- AND PROTON-BEAM RADIOTHERAPIES.
    Newhauser WD; Schneider C; Wilson L; Shrestha S; Donahue W
    Radiat Prot Dosimetry; 2018 Aug; 180(1-4):245-251. PubMed ID: 29177488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of developing a second cancer after receiving craniospinal proton irradiation.
    Newhauser WD; Fontenot JD; Mahajan A; Kornguth D; Stovall M; Zheng Y; Taddei PJ; Mirkovic D; Mohan R; Cox JD; Woo S
    Phys Med Biol; 2009 Apr; 54(8):2277-91. PubMed ID: 19305036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
    Weber DC; Trofimov AV; Delaney TF; Bortfeld T
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.
    Taddei PJ; Mirkovic D; Fontenot JD; Giebeler A; Zheng Y; Kornguth D; Mohan R; Newhauser WD
    Phys Med Biol; 2009 Apr; 54(8):2259-75. PubMed ID: 19305045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A general model for stray dose calculation of static and intensity-modulated photon radiation.
    Hauri P; Hälg RA; Besserer J; Schneider U
    Med Phys; 2016 Apr; 43(4):1955. PubMed ID: 27036591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy.
    Fontenot JD; Bloch C; Followill D; Titt U; Newhauser WD
    Phys Med Biol; 2010 Dec; 55(23):6987-98. PubMed ID: 21076196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An indirect in vivo dosimetry system for ocular proton therapy.
    Carnicer A; Letellier V; Rucka G; Angellier G; Sauerwein W; Hérault J
    Radiat Prot Dosimetry; 2014 Oct; 161(1-4):373-6. PubMed ID: 24222711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stray neutron radiation exposures from proton therapy: physics-based analytical models of neutron spectral fluence, kerma and absorbed dose.
    Shrestha S; Newhauser WD; Donahue WP; Pérez-Andújar A
    Phys Med Biol; 2022 Jun; 67(12):. PubMed ID: 35613603
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma.
    Taddei PJ; Howell RM; Krishnan S; Scarboro SB; Mirkovic D; Newhauser WD
    Phys Med Biol; 2010 Dec; 55(23):7055-65. PubMed ID: 21076199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
    Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shielding implications for secondary neutrons and photons produced within the patient during IMPT.
    DeMarco J; Kupelian P; Santhanam A; Low D
    Med Phys; 2013 Jul; 40(7):071701. PubMed ID: 23822405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
    Baumert BG; Norton IA; Lomax AJ; Davis JB
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the secondary neutral radiation in proton therapy: toward an indirect in vivo dosimetry.
    Carnicer A; Letellier V; Rucka G; Angellier G; Sauerwein W; Herault J
    Med Phys; 2012 Dec; 39(12):7303-16. PubMed ID: 23231280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
    Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
    Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer.
    Taddei PJ; Fontenot JD; Zheng Y; Mirkovic D; Lee AK; Titt U; Newhauser WD
    Phys Med Biol; 2008 Apr; 53(8):2131-47. PubMed ID: 18369278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.
    Wang X; Krishnan S; Zhang X; Dong L; Briere T; Crane CH; Martel M; Gillin M; Mohan R; Beddar S
    Med Dosim; 2008; 33(4):259-67. PubMed ID: 18973852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RADIATION PROTECTION MEASUREMENTS WITH THE VARIANCE-COVARIANCE METHOD IN THE STRAY RADIATION FIELDS FROM PHOTON AND PROTON THERAPY FACILITIES.
    Lillhök J; Persson L; Andersen CE; Dasu A; Ardenfors O
    Radiat Prot Dosimetry; 2018 Aug; 180(1-4):338-341. PubMed ID: 29036696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system.
    Lehmann J; Hartmann Siantar C; Wessol DE; Wemple CA; Nigg D; Cogliati J; Daly T; Descalle MA; Flickinger T; Pletcher D; Denardo G
    Phys Med Biol; 2005 Mar; 50(5):947-58. PubMed ID: 15798267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy.
    Fogliata A; Scorsetti M; Navarria P; Catalano M; Clivio A; Cozzi L; Lobefalo F; Nicolini G; Palumbo V; Pellegrini C; Reggiori G; Roggio A; Vanetti E; Alongi F; Pentimalli S; Mancosu P
    Acta Oncol; 2013 Apr; 52(3):545-52. PubMed ID: 22671576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.